We are live on ! Find out more
BIND

BIND THERAPEUTICS INC
BIND

Delisted

BIND was delisted on the 29th of July, 2016.

Back to rankings

45 hedge funds and large institutions have $55.6M invested in BIND THERAPEUTICS INC in 2014 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

58% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 12

9% more capital invested

Capital invested by funds: $51.2M → $55.6M (+$4.36M)

7% more funds holding

Funds holding: 42 → 45 (+3)

Holders
45
Holders Change
+3
Holders Change %
+7.14%
% of All Funds
1.3%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
10
Increased
19
Reduced
12
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OM
Opaleye Management
Massachusetts
+$3.55M
2
BA
BlackRock Advisors
Delaware
+$1.54M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.05M
4
RPAM
Rhenman & Partners Asset Management
Sweden
+$784K
5
Millennium Management
Millennium Management
New York
+$558K

Top Sellers

Rank Fund Capital Flow
1
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$7.64M
2
EA
Emerald Advisers
Pennsylvania
-$4.93M
3
DM
Deerfield Management
New York
-$3.87M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$937K
5
RA
Royce & Associates
New York
-$830K
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
26
Prelude Capital Management
New York
$155K – – –
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$115K – – –
Marshall Wace
28
Marshall Wace
United Kingdom
$99K +$109K +8,316 New
Morgan Stanley
29
Morgan Stanley
New York
$68K -$46.1K -3,530 -38%
TA
30
Teachers Advisors
New York
$63K – – –
BJ
31
BlackRock Japan
Japan
$63K +$63.5K +4,860 +1,289%
Wells Fargo
32
Wells Fargo
California
$60K +$28.6K +2,193 +79%
TDC
33
Thompson Davis & Co
Virginia
$60K +$45.7K +3,500 +233%
NFA
34
Nationwide Fund Advisors
Ohio
$47K – – –
AIG
35
American International Group
New York
$43K +$1.12K +86 +2%
Citigroup
36
Citigroup
New York
$43K -$26.7K -2,046 -36%
PP
37
Palladium Partners
Virginia
$43K +$47K +3,600 New
U
38
UBS
Switzerland
$24K +$5.22K +400 +25%
Deutsche Bank
39
Deutsche Bank
Germany
$23K -$308K -23,590 -92%
TRCT
40
Tower Research Capital (TRC)
New York
$5K +$5.33K +408 New
Barclays
41
Barclays
United Kingdom
$3K +$2.01K +154 +179%
Bank of America
42
Bank of America
North Carolina
$1K +$144 +11 +11%
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$1K +$1.31K +100 New
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$236 +$326 +25 New
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2 +$1.79K +137 New
DM
46
Deerfield Management
New York
– -$3.87M -256,384 Closed
Alyeska Investment Group
47
Alyeska Investment Group
Illinois
– -$937K -62,087 Closed
RA
48
Royce & Associates
New York
– -$830K -55,000 Closed
PAM
49
Panagora Asset Management
Massachusetts
– -$335K -22,179 Closed
SO
50
STRS Ohio
Ohio
– -$27.4K -2,100 Closed
1
2
3

BIND Hedge Fund Activity: Q1 2014 in Review

45 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in BIND THERAPEUTICS INC (BIND) for Q1 2014, worth a combined $55.6M — up 8.5% from $51.2M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new BIND positions and 6 closed out — a net gain of 4 holders — while 19 added to existing stakes and 12 trimmed.

The largest buyer was Opaleye Management, adding an estimated $3.55M. The largest seller was Emerald Mutual Fund Advisers Trust, cutting an estimated $7.64M.

  • 45 institutional investors held BIND THERAPEUTICS INC (BIND) as of Q1 2014, up from 42 in Q4 2013.
  • Funds reported $55.6M of BIND THERAPEUTICS INC stock for Q1 2014, up 8.5% quarter-over-quarter.
  • 10 funds opened new BIND THERAPEUTICS INC positions in Q1 2014 and 6 closed out, a net change of +4 holders.
  • The largest BIND THERAPEUTICS INC buyer in Q1 2014 was Opaleye Management, an estimated $3.55M added.
  • The largest BIND THERAPEUTICS INC seller in Q1 2014 was Emerald Mutual Fund Advisers Trust, an estimated $7.64M sold.

Based on aggregated 13F filings for Q1 2014.